PRHSX vs. PRGTX

In the year-to-date period, PRHSX achieves a -8.25% return, which is significantly lower than PRGTX's 36.57% return. Over the past 10 years, PRHSX has underperformed PRGTX with an annualized return of 1.66%, while PRGTX has yielded a comparatively higher 5.54% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

PRHSX has a 0.80% expense ratio, which is lower than PRGTX's 0.95% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and T. Rowe Price Global Technology Fund (PRGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PRHSX Sharpe Ratio is -0.32, which is lower than the PRGTX Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of PRHSX and PRGTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither PRHSX nor PRGTX has paid dividends to shareholders.

The maximum PRHSX drawdown since its inception was -47.79%, smaller than the maximum PRGTX drawdown of -73.10%. Use the drawdown chart below to compare losses from any high point for PRHSX and PRGTX. For additional features, visit the drawdowns tool.

T. Rowe Price Health Sciences Fund (PRHSX) has a higher volatility of 12.44% compared to T. Rowe Price Global Technology Fund (PRGTX) at 5.38%. This indicates that PRHSX's price experiences larger fluctuations and is considered to be riskier than PRGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.